Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.

This Cochrane review examined treatments for abdominal pain in Crohn's disease and inflammatory bowel disease (IBD). Researchers analyzed 14 studies involving 743 participants who tried various interventions including dietary changes, acupuncture with moxibustion, stress management, yoga, and medications. Abdominal pain affects 20-50% of people with Crohn's disease even when their disease is in remission, making it a significant quality-of-life issue.

One study compared medicine-separated moxibustion combined with acupuncture (51 patients) to a sham treatment using wheat bran-separated moxibustion with shallow acupuncture (51 patients) in people with Crohn's disease. Unfortunately, the way pain data was reported made it unclear whether this treatment was effective. The review found low-certainty evidence that one treatment—transcranial direct current stimulation—may help reduce pain intensity compared to fake stimulation. However, researchers could not draw conclusions about the effectiveness of any other interventions, including acupuncture with moxibustion, due to the very low quality of evidence.

The main problem was that most studies were small, measured pain differently, and had methodological limitations. Side effects were generally minimal across all non-drug treatments studied. What this means for patients: While acupuncture combined with moxibustion is sometimes used for Crohn's-related abdominal pain, there isn't enough high-quality evidence yet to confirm whether it works. More rigorous research is needed before clear recommendations can be made. If considering acupuncture for IBD-related pain, seek treatment from a licensed acupuncturist experienced in treating digestive conditions.

This Cochrane systematic review evaluated interventions for abdominal pain management in Crohn's disease and IBD, including 14 studies with 743 participants. One study (n=102) compared medicine-separated moxibustion combined with acupuncture versus wheat bran-separated moxibustion with shallow acupuncture in Crohn's disease patients. Pain intensity and frequency data reporting was unclear, precluding meaningful analysis. The review identified low-certainty evidence that transcranial direct current stimulation may improve pain intensity (MD -1.65, 95% CI -3.29 to -0.01) compared to sham. All other interventions, including the acupuncture-moxibustion combination, yielded very low-certainty evidence due to sparse data, risk of bias, and clinical heterogeneity. Adverse events in non-pharmacological interventions were minimal. Clinical takeaway: Current evidence is insufficient to support acupuncture with moxibustion for IBD-related abdominal pain. Practitioners should counsel patients about the lack of robust evidence while acknowledging the generally safe profile of these interventions.